sacituzumab govitecan
gilead sciences
['bcsm', 'tropics-02', 'breast']
 asco expert discusses the results of the tropics-02 study, which showed a novel agent increased pfs for pts with hr+/her2- advanced #breastcancer #asco22 #bcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.